National Projects

  • “Emblematic action to handle SARS-CoV-2 infection: Epidemiological study in Greece via extensive testing for viral and antibody detection, sequencing of the virome and genetic analysis of the carriers” Funded by GSRT No 2020ΣΕ01300001, 2020-2022
  • “Revealing senescent cells with novel and innovative compounds” Funded by GSRT with 509.568,02 Euros, “EPAnEK” program, 2020-2023
  • “Hippo pathway in genome and epigenome maintenance” Funded by GSRT with 180.000 euros, HFRI code 775, 2018-2021
  • “Interrogating the Pathophysiological Consequences of deregulated Replication Licensing” Funded by GSRT with 180.000 euros, HFRI code 3782, 2020-2023
  • “Revealing senescent cells with novel and innovative compounds” Funded by GSRT with 998.340 Euros, “EPAnEK” program, 2018-2021
  • IKY-Simens Excellence (Aristeia) 2016 grant application
  • “Transcriptional reprogramming features triggered by oncogenic Cdc6” Funded by the GSRT with 200.000 Euros, “ARISTEIA II” program, project code 3020, 2014-2015
  • “Gene therapy in Cystic Fibrosis: Expression of CFTR gene by human artificial chromosomes” Funded by GSRT with 78.000 Euros, “ENTER” prorgam, project code SARG 70/3/8660, 2006-2007
  • “Study of the deregulation of DNA licensing factors, the activation of DNA Damage response and their relation with kinetic parameters and ploidy in Non-Small Cell Lung Cancer” Funded by GSRT with 138.480 Euros, “PENED 2003” program, project code 5325/10.05.2004
  • “Study of the changes in the genetic locus KIP2/CDKN1C and its expression in Non-Small Cell Lung Cancer” Funded by the GSRT with 100.000 Euros, “Pythagoras II” program, project code: 70/3/7953 SARG, 2005-2006
  • “Study of the effect of genotoxic agents on the survival of colon cancer cell lines, emphasis on the E2F1–dependent apoptosis” Funded by the GSRT with 100.000 Euros, “Pythagoras II” program, project code 70/3/7952 SARG, 2005-2006
  • “Sensitivity of cancer cells to chemotherapeutic drugs affecting the microtubule integrity: molecular mechanisms related to the expression of the oncosuppressive protein p53 and the oncogene c-mos” Funded by the GSRT with 30.000 Euros, “Heraklitos” program, project code 70/3/7211, 2005
  • “Study of the E2F family of transcriptional factors in the commonest malignancies” Funded with 100.000 Euros by the GSRT, “Pythagoras” program, project code: 20.2.04/10856, 2004
  • “Carcinogenesis in the respiratory system. Defects in the signaling pathways” Funded by the GSRT, “Kapodistrias” program, project code 70/4/4281, 4.000 euros, 2003
  • “Carcinogenesis in the respiratory system. Defects in cell adhesion mechanisms” Funded by the GSRT, “Kapodistrias” program, project code 70/4/4591, 4.000 euros, 2003
  • “The role of mutant p53 in disturbing the negative feedback mechanism p53-MDM2 in lung cancer” Funded by GSRT with 5.000.000 drachmas, Activity 2.2, Call ΥΠΕΡ97, Project code 97ΥΠ218, July 1998 – March 2001
  • “Cancer Biology: gene analysis and in vivo imaging of receptors - radiotherapy” Funded by the Framework Program Research and Technology (FPRT) II, Activity 1.2, GSRT, Project code: 97 ΕΚΒΑΝ2-112, 1-9-1998 – 31-8-2001. Funded by the GSRT with 17.000.000 drachmas
  • “Carcinogenesis in the upper and lower respiratory system”. Funded by the National Board of Health with 50.000 drachmas, 1996-1997
  • “Molecular Genetics: a. national registry for inheritable diseases in Greece, training of the medical and nursing staff, b. use of molecular biology techniques for the recognition of the responsible gene for the inheritable colon adenocarcinoma”. Funded by the Special Account for Research Grants (SARG) with 500.000 drachmas, 1997
  • “Breast carcinogenesis”. Funded by the National Board of Health with 5.000.000 drachmas, 1996
  • “Application of artificial intelligence for the development of drugs and new therapies” Flagship Initiative funded by the National Public Investment Program of the Ministry of Development and Investment / General Secretariat for Research and Innovation (2020ΣΜ01300002), in collaboration with Intelligencia.

VG New

Prof. Vassilis G. Gorgoulis

Laboratory of Histology-Embryology
Molecular Carcinogenesis Group
Medical School
National and Kapodistrian University of Athens

 

 

Chair of Clinical Molecular Pathology,

Ninewells Hospital and School of Medicine

 

University of Dundee, Dundee, UK

 

Biomedical Research Foundation of the Academy of Athens

 

Faculty Institute for Cancer Sciences, University of Manchester,
Manchester Academic Health Science Centre, Manchester, UK

Manchester Centre for Cellular Metabolism,
University of Manchester, Manchester Academic Health Science Centre, Manchester

 

EMBO member

 

European Academy
of Cancer Sciences member

 

Academia Europaea member

 

Intelligencia.ai, 180 Varick Street, 6th Floor, New York, NY 10014, USA 

 

SenTraGorΤΜ

 

 

 

Office Tel: 0030 210-7462352
Fax: 0030 210-7462340
E-mail: vgorg@med.uoa.gr

News

Error: No articles to display

Also see...

Newsletters

Copyright ©2011-2015, Prof. Gorgoulis Powered by AVMap